GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses
GSK begins shipping FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT PHILADELPHIA–(BUSINESS WIRE)–#Flu–GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2022-23 season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for … [Read more…]
